These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10565797)

  • 1. Mouse models for internal radiation dosimetry.
    Fisher DR; Hui TE
    J Nucl Med; 1999 Nov; 40(11):1969-70. PubMed ID: 10565797
    [No Abstract]   [Full Text] [Related]  

  • 2. A mouse bone marrow dosimetry model.
    Muthuswamy MS; Roberson PL; Buchsbaum DJ
    J Nucl Med; 1998 Jul; 39(7):1243-7. PubMed ID: 9669402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved prediction of myelotoxicity using a patient-specific imaging dose estimate for non-marrow-targeting (90)Y-antibody therapy.
    Shen S; Meredith RF; Duan J; Macey DJ; Khazaeli MB; Robert F; LoBuglio AF
    J Nucl Med; 2002 Sep; 43(9):1245-53. PubMed ID: 12215566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of methods for red marrow dosimetry based on patients undergoing radioimmunotherapy.
    Hindorf C; Lindén O; Tennvall J; Wingårdh K; Strand SE
    Acta Oncol; 2005; 44(6):579-88. PubMed ID: 16165917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow dosimetry for radioimmunotherapy: theoretical considerations.
    Sgouros G
    J Nucl Med; 1993 Apr; 34(4):689-94. PubMed ID: 8455089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
    Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internal dosimetry in the use of radiopharmaceuticals in therapy--science at a crossroads?
    Stabin MG
    Cancer Biother Radiopharm; 1999 Apr; 14(2):81-9. PubMed ID: 10850291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical determination of patient-specific marrow dose using radioactivity concentration in blood and body.
    Shen S; DeNardo GL; Sgouros G; O'Donnell RT; DeNardo SJ
    J Nucl Med; 1999 Dec; 40(12):2102-6. PubMed ID: 10616892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
    Konijnenberg MW; Bijster M; Krenning EP; De Jong M
    J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic dosimetry of bone marrow: induction of micronuclei in reticulocytes after exposure to 32P and 90Y.
    Lenarczyk M; Goddu SM; Rao DV; Howell RW
    J Nucl Med; 2001 Jan; 42(1):162-9. PubMed ID: 11197968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone and bone marrow spaces in dosimetry of beagles skeletons.
    Momeni MH; Pool RR
    Health Phys; 1975 Dec; 29(6):877-81. PubMed ID: 1201957
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
    Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
    J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorbed fractions for alpha-particles in tissues of trabecular bone: considerations of marrow cellularity within the ICRP reference male.
    Watchman CJ; Jokisch DW; Patton PW; Rajon DA; Sgouros G; Bolch WE
    J Nucl Med; 2005 Jul; 46(7):1171-85. PubMed ID: 16000287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
    Casey JL; Pedley RB; King DJ; Green AJ; Yarranton GT; Begent RH
    Br J Cancer; 1999 Nov; 81(6):972-80. PubMed ID: 10576653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetry and radioimmunotherapy of non-Hodgkin's lymphoma.
    Postema EJ
    J Nucl Med; 2004 Dec; 45(12):2126-7; author reply 2127. PubMed ID: 15585492
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biological dosimetry in ionizing radiation exposure (a review of the literature)].
    Vladimirov VG; Smirnov AD
    Voen Med Zh; 1978 Feb; (2):76-9. PubMed ID: 345615
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood-based red marrow dosimetry: where's the beef?
    Siegel JA; Sparks RB; Sharkey RM; Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Meredith RF; Sgouros G; Stabin MG
    J Nucl Med; 2005 Aug; 46(8):1404-6; author reply 1405-6. PubMed ID: 16085600
    [No Abstract]   [Full Text] [Related]  

  • 18. The dosimetry of bone incorporating alpha-emitting radionuclides.
    Montelius A; Burlin TE
    Br J Radiol; 1984 Jul; 57(679):609-16. PubMed ID: 6733407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
    Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
    Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of total-body mass on the scaling of S-factors for patient-specific, blood-based red-marrow dosimetry.
    Traino AC; Ferrari M; Cremonesi M; Stabin MG
    Phys Med Biol; 2007 Sep; 52(17):5231-48. PubMed ID: 17762083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.